Drug Topics
AUGUST 31, 2022
Drug Topics® is joined by Joseph Mann, MSN, FNP-C, to discuss pharmacy’s fast-expanding role in COVID care, variant BA.5’s diagnostic impact, and the benefits of different tests available — including how technology behind a smartphone-integrated home test creates a fluid experience for patients.
Pharmacy Times
AUGUST 31, 2022
Data have shown there is a rising need for mental health and substance use disorder services, yet there is a shortage of psychiatrists in the country that is estimated to worsen by 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 31, 2022
Drug Topics® sits down with George Euson, whose decades of experience in regulatory compliance for the pharmacy industry provide an insider's perspective on threats your business — and your patients — face today.
Pharmacy Times
AUGUST 31, 2022
Desmond Hunt, PhD, senior principal scientist at US Pharmacopeia (USP), discusses the standards and resources that USP has recently published or is looking at now on the subject of pharmacy in transit.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
AUGUST 31, 2022
Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The original agreement last year focused on melanoma patients who are receiving BRAF/MEK combination therapies – specifically Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) drugs – and has resulted in the development of a digital module tailored to their needs.
Pharmacy Times
AUGUST 31, 2022
With these bivalent vaccine authorizations, the monovalent mRNA COVID-19 vaccines are still not authorized as booster doses for individuals 12 years of age and older.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 31, 2022
A gastroenterologist, Dr. Bincy Abraham, provides an overview of C. difficile infection (CDI) in patients with inflammatory bowel disease (IBD).
STAT
AUGUST 31, 2022
Despite a recent taxpayer-subsidized boon , the hospital industry spent the last several months lobbying for additional federal dollars amid warnings about the continued spread of Covid-19 and inflation’s impact on the nation’s health care system. Those efforts bore fruit: Medicare recently granted hospitals the largest price increase since 1998.
Pharmacy Times
AUGUST 31, 2022
Lawrence H. Summers, former US Secretary of the Treasury, explains that he is optimistic regarding pharmacy’s increasing role in fighting future pandemics.
STAT
AUGUST 31, 2022
WASHINGTON — Federal health officials are starting to push new, variant-targeting vaccines that they say will curb a winter coronavirus wave and protect America’s most medically vulnerable people. The question is whether Americans feel any urgency to get them. The updated vaccines from Moderna and Pfizer and BioNTech, authorized Wednesday by the Food and Drug Administration, are tailored to fighting back the dominant BA.4 and BA.5 strains.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 31, 2022
Some function is partially restored once smokers kick the habit, results presented at the European Society of Cardiology Congress 2022 show.
STAT
AUGUST 31, 2022
Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m picking up the baton from Allison as we continue to fill in for Ed this week. I’m not a coffee drinker, but I’ve poured myself a cup of water. No ice, though, as I find it dilutes the flavor. Jokes aside, here are some newsy items for you to peruse this morning.
Pharmacy Times
AUGUST 31, 2022
The FDA approval makes olipudase alfa the first approved drug to target the physiological symptoms of the disease.
Fossil Remedies
AUGUST 31, 2022
Do you think that India is a great place to launch a pharma business? Yes, indeed it is. In the past few decades, the Indian economy has done remarkably well. Many sectors have performed well, and the pharma sector is one of them. And the journey of growth has not ended yet. There is a great potential still, to prosper and flourish. Those, who don’t mind taking a risk in the business must reap the opportunity by launching a pharma company.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
AUGUST 31, 2022
Drs. Lodise and Feuerstadt discuss educational opportunities to combat and reduce C. difficile infection (CDI).
Board Vitals - Pharmacist
AUGUST 31, 2022
The NFL season is finally here. While the players prepare for the game on the field, another team is watching for something more important off the field. Four specially trained “spotters” watch every game from the stadium press box and pull players who may have been involved in concussion-causing collisions. The reason is clear; the National Football League (NFL) reported 224 concussions in 2019.
Drug Topics
AUGUST 31, 2022
Timber Pharmaceuticals’ CONTROL study evaluated the safety and efficacy of the topical isotretinoin.
PharmaVoice
AUGUST 31, 2022
Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is stepping into a new role and a new title as chief delivery officer at Thread.
Drug Topics
AUGUST 31, 2022
These bivalent formulations include an mRNA component common to the BA.4 and BA.5 Omicron variant.
Pharmacy Times
AUGUST 31, 2022
The benefits of taking a daily statin may improve as a patient grows older.
Drug Store News
AUGUST 31, 2022
Welly Remedies is a line of over-the-counter medications and dietary supplements.
Drug Topics
AUGUST 31, 2022
New research indicates the medication has cardioprotective properties.
Pharmacy Times
AUGUST 31, 2022
Paul Forsberg, PharmD, BCOP, MHA, director of Pharmacy Services at Minnesota Oncology discusses how pharmacists can remain on top of shifts in the nature of biosimilar payer benefit design.
Drug Topics
AUGUST 31, 2022
Take a look back at our most popular news from August 2022.
Med Ed 101
AUGUST 31, 2022
Drug interactions don’t come to the top of my mind when I see GLP-1 agonists in use. We are fortunate that they do not have a lot of significant interactions, but I don’t think you should forget about them altogether. I’ve provided a list below of my top 3 drug interactions with GLP-1 agonists. Insulin […]. The post 3 Drug Interactions With GLP-1 Agonists appeared first on Med Ed 101.
pharmaphorum
AUGUST 31, 2022
Amgen’s pathfinder KRAS inhibitor Lumakras has been shown to be effective in KRAS-mutated non-small cell lung cancer (NSCLC) in a phase 3 trial that should serve as a confirmation study for its earlier accelerated approval in this setting. The 345-subject CodeBreaK 200 trial of once-daily Lumakras (sotorasib) met its primary objective of improving progression-free survival (PFS) compared to chemotherapy with intravenous docetaxel in KRAS G12C-mutated NSCLC patients previously treated with
Pharmacy Times
AUGUST 31, 2022
Investigational targeted B-cell therapy demonstrates superior efficacy compared with teriflunomide, a commonly prescribed treatment for MS.
pharmaphorum
AUGUST 31, 2022
As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron subvariants BA.5 and BA.5. The US regulator has cleared a 30 µg booster dose of a new version of Pfizer’s Comirnaty shot – 15 µg encoding the spike protein of the original wild-type SARS-CoV-2 strain and 15-µg of mRNA coding for Omicron BA.4/BA.5 – for people aged 12 and over.
Pharmacy Times
AUGUST 31, 2022
Ozanimod (Zeposia) is indicated for the treatment of multiple sclerosis and moderately to severely active ulcerative colitis in adults.
BioPharm
AUGUST 31, 2022
Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.
Pharmaceutical Technology
AUGUST 31, 2022
Availability of labour is an important factor for foreign investors, with the education and skill sets found within that labour force being a decisive driver when it comes to FDI site selection. Data from the UN Conference on Trade and Development’s World Investment Report 2020 and the World Economic Forum’s Global Competitiveness Report 2019 indicates that countries with a higher-skilled and better-educated workforce attract more greenfield FDI projects, but how does a country ensure its workfo
Pharma Marketing Network
AUGUST 31, 2022
Video is, without a doubt, revolutionizing the pharmaceutical industry. It presents a tremendous opportunity for pharma and healthcare brands as it is one of the most effective mediums for delivering your message and results in high conversion rates. Why Video Works. We live in a fast-paced, short-lived world that is full of endless information. For digital users especially, this combination means drastically decreasing attention spans.
Pharmaceutical Technology
AUGUST 31, 2022
Over the last few years, the trend for wearables has shown the potential benefits of transforming healthcare through digital technologies. Alongside fitness trackers and smartwatches, there are also medical devices used to monitor a patient’s vitals and some even contain SIM cards to enable two-way communication. Devices such as insulin pumps, heart pacemakers, and inhalers can track patient data in real-time and transmit to the user’s phone, an app, or their doctor, making the data immediately
pharmaphorum
AUGUST 31, 2022
Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the US, as the UK biotech reports confirmatory phase 3 data ahead of an FDA filing later this month. The results of the FM71 trial of MED3000 showed that the topical gel formulation achieved a significant improvement in erectile function compared to baseline at 24 weeks, across the range of mild, moderate and severe ED.
Expert insights. Personalized for you.
187 
Let's personalize your content